R. W. Baldwin
About
In The Last Decade
R. W. Baldwin
34 papers receiving 898 citations
Peers
Comparison fields: 5 of 113
- Oncology 307
- Pathology and Forensic Medicine 294
- Immunology 284
- Molecular Biology 212
- Radiology, Nuclear Medicine and Imaging 186
Countries citing papers authored by R. W. Baldwin
This map shows the geographic impact of R. W. Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. W. Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. W. Baldwin more than expected).
Fields of papers citing papers by R. W. Baldwin
This network shows the impact of papers produced by R. W. Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. W. Baldwin. The network helps show where R. W. Baldwin may publish in the future.
Co-authorship network of co-authors of R. W. Baldwin
This figure shows the co-authorship network connecting the top 25 collaborators of R. W. Baldwin. A scholar is included among the top collaborators of R. W. Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. W. Baldwin. R. W. Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | The FDA regulatory methods validation program for new and abbreviated new drug applications | 4 |
| 3 | 23 | |
| 4 | 30 | |
| 5 | Monoclonal antibodies and immunoconjugates in cancer treatment | 1 |
| 6 | 17 | |
| 7 | 91 | |
| 8 | Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugates. | 5 |
| 9 | Accelerated catabolism of an anti tumor monoclonal antibody in nude mice bearing human tumor xenografts | 1 |
| 10 | 18 | |
| 11 | 8 | |
| 12 | 5 | |
| 13 | Sapporo Cancer Seminar: Escape of Tumor Cells from Immune Controls | 2 |
| 14 | 2 | |
| 15 | 20 | |
| 16 | Secondary spread of cancer | 38 |
| 17 | Biology and biochemistry | 1 |
| 18 | Experimental and Clinical Effects of L-Asparaginase | 2 |
| 19 | Progress in Experimental Tumor Research: Vol. 13: Immunological Aspects of Neoplasia | 17 |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.